These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3075631)

  • 21. Correlation viability/morphology in Mycobacterium leprae.
    Silva MT; Macedo PM; Portaels F; Pattyn SR
    Acta Leprol; 1984; 2(2-4):281-91. PubMed ID: 6398588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative assessment of viability of M.leprae by mouse foot-pad and fluorescent staining techniques.
    Sreevatsa ; Katoch VM
    Indian J Lepr; 1994; 66(4):455-62. PubMed ID: 7714355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Susceptibility of severe combined immunodeficient mice to Mycobacterium leprae.
    Ishaque M; Sticht-Groh V; Togola D
    Microbios; 1996; 88(354):19-26. PubMed ID: 9121376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro and in vivo effects of N-methyl-3,5-dichloro-benzylamine hydrochloride on Mycobacterium leprae.
    Dhople AM; Strong LC; Meindl W; Schoenenberger H; Gardner GD
    Arzneimittelforschung; 1991 Mar; 41(3):253-6. PubMed ID: 1867663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of quantitative relationship between viability determination in leprosy by MFP, ATP bioluminescence and gene amplification assay.
    Gupta UD; Katoch K; Sharma RK; Singh HB; Natragan M; Singh D; Sharma VD; Chauhan DS; Das R; Srivastava K; Katoch VM
    Int J Lepr Other Mycobact Dis; 2001 Dec; 69(4):328-34. PubMed ID: 12035294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Superiority of the neonatally thymectomized Lewis rat (NTLR) to monitor a clinical trial in lepromatous leprosy of the two regimens of rifampin and dapsone.
    Gelber RH; Humphres RC; Fieldsteel AH
    Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):273-83. PubMed ID: 3522770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activities of pefloxacin and ciprofloxacin against Mycobacterium leprae in the mouse.
    Guelpa-Lauras CC; Perani EG; Giroir AM; Grosset JH
    Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):70-7. PubMed ID: 3549940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of a viability-staining method for Mycobacterium leprae derived from the athymic (nu/nu) mouse foot pad.
    Lahiri R; Randhawa B; Krahenbuhl J
    J Med Microbiol; 2005 Mar; 54(Pt 3):235-242. PubMed ID: 15713606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activity of ascorbic acid in inhibiting the multiplication of M. leprae in the mouse foot pad.
    Hastings RC; Richard V; Christy SA; Morales MJ
    Int J Lepr Other Mycobact Dis; 1976; 44(4):427-30. PubMed ID: 798727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Current data on the bacteriology of leprosy].
    Grosset J; Guelpa-Lauras CC; Lecoeur H
    Acta Leprol; 1982; (86-87):35-45. PubMed ID: 6815996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of brodimoprim on Mycobacterium leprae in vitro and in mouse foot-pads.
    Dhople AM; Ortega I; Seydel JK; Gardner GD
    Indian J Lepr; 1990; 62(1):76-86. PubMed ID: 2193064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro studies on the effect of levamisole in lepromatous leprosy.
    Birdi TJ; Mistry NF; Mahadevan PR; Antia NH
    J Clin Lab Immunol; 1984 Feb; 13(2):93-6. PubMed ID: 6374154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiplication of Mycobacterium leprae in the nude mouse, and some applications of nude mice to experimental leprosy.
    McDermott-Lancaster RD; Ito T; Kohsaka K; Guelpa-Lauras CC; Grosset JH
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):889-95. PubMed ID: 3325583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Action of desoxyfructo-serotonin on Mycobacterium leprae. Results of inoculation of human biopsy specimens in the mouse after a year of treatment].
    Ferracci C; Baquillon G; Pattyn SR
    Acta Leprol; 1983; 1(4):233-5. PubMed ID: 6377799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Search for newer antileprosy drugs.
    Dhople AM
    Indian J Lepr; 2000; 72(1):5-20. PubMed ID: 10935183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug resistance in leprosy.
    Matsuoka M
    Jpn J Infect Dis; 2010 Jan; 63(1):1-7. PubMed ID: 20093754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Newer drugs in leprosy.
    Grosset JH
    Int J Lepr Other Mycobact Dis; 2001 Jun; 69(2 Suppl):S14-8. PubMed ID: 11757174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Viability and drug susceptibility testing of M. leprae using mouse footpad in 37 relapse cases of leprosy.
    Shetty VP; Wakade AV; Ghate S; Pai VV; Ganapati R; Antia NH
    Int J Lepr Other Mycobact Dis; 2003 Sep; 71(3):210-7. PubMed ID: 14608816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A brief review of experiences with short-term clinical trials monitored by mouse-foot-pad-inoculation.
    Shepard CC
    Lepr Rev; 1981 Dec; 52(4):299-308. PubMed ID: 7031389
    [No Abstract]   [Full Text] [Related]  

  • 40. Prevalence of secondary dapsone resistance in Nepal.
    Samuel NM; Samuel S; Loudon J; Neupani K; Adiga RB
    Indian J Lepr; 1984; 56(4):823-7. PubMed ID: 6398344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.